Latest Biotech News

Scientists at the Korea Research Institute of Bioscience and Biotechnology have developed a cutting-edge nanobody-based therapeutic modality specifically targeting lung cancer cells. The approach...

Groundbreaking research reveals a complex interplay between regulatory T cells (Tregs) and pro-inflammatory Th17 cells mediated by a balance of cytokines including TGF-β, IL-6, and IL-2. This...

In a significant policy move, the US Department of Health and Human Services reinstated the Task Force on Safer Childhood Vaccines, disbanded since 1998. This action follows a lawsuit filed by the...

German researchers from the University of Cologne have optimized the CUT&Tag assay by reducing salt concentrations in buffers, overcoming prior limitations preventing measurement of transcription...

Kriya Therapeutics, a biotech company focused on gene therapy, has secured a $313 million funding round, marking a significant financial boost for its development programs. Operating between North...

The biopharmaceutical industry experienced a record-high surge in deal values totaling $164 billion in the first seven months of 2025, a 36% increase year-over-year. However, the total number of...

The U.S. Food and Drug Administration has granted a rapid, full approval to Precigen Inc.'s gene therapy Papzimeos for recurrent respiratory papillomatosis (RRP), a rare disease causing benign...

Pfizer's sickle cell therapy candidate inclacumab failed to demonstrate efficacy in a pivotal Phase 3 trial, according to recent announcements. This failure follows Pfizer's voluntary withdrawal...

Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital have achieved the first real-time, three-dimensional recording of human embryo implantation on synthetic...

Emerging studies are advancing precision oncology and immunotherapy through novel biomarker discoveries and drug development. A Fudan University-led study introduced a blood test predicting...

Breakthrough clinical developments are emerging in neonatal and pediatric care. Airway Therapeutics announced an expanded multinational Phase III trial of zelpultide alfa, targeting...

Recent research breakthroughs deepen understanding of gene regulation and chromatin dynamics impacting various diseases. German scientists developed a buffer modification enabling CUT&Tag assays...

The biopharma sector saw record-breaking deal values in the first seven months of 2025, totaling $164 billion in non-M&A deals, a 36% increase over 2024. However, 2025 witnessed a notable IPO...

Innovative biotechnologies addressing environmental and structural challenges have advanced significantly. Studies reveal the seismic vulnerability of unreinforced masonry facades improved by...

Recent studies provide new perspectives on mental health and neurological disorders. Research links loneliness with depression in adolescent and young adult cancer survivors, highlighting...

Cutting-edge developments are reshaping biotech through AI and computational advances. Large language models are revolutionizing drug discovery, enhancing speed and accuracy in molecular design....

The U.S. Food and Drug Administration granted a swift and full approval to Precigen Inc.'s gene therapy, Papzimeos (zopapogene imadenovec), targeting recurrent respiratory papillomatosis (RRP)....

Pfizer announced the failure of its Phase 3 trial for inclacumab, a sickle cell disease candidate acquired through its $5.4 billion deal for Global Blood Therapeutics. The investigational drug did...

Researchers at the Institute for Bioengineering of Catalonia and Dexeus University Hospital achieved the first ever real-time three-dimensional imaging of human embryo implantation into a collagen...

New research led by Cheng, Nan, and Ji uncovers a paradoxical immunological mechanism wherein regulatory T cells (Tregs) boost the pro-inflammatory T helper 17 (Th17) cell population through an...